Bruton’s tyrosine kinase (BTK) inhibitors in treating cancer: a patent review (2010-2018)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bruton’s tyrosine kinase (BTK) inhibitors in treating cancer: a patent review (2010-2018)

Published:2019-03-19 Issue:4 Volume:29 Page:217-241
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Feng Yifan¹,Duan Weiming¹,Cu Xiaochuan²,Liang Chengyuan³,Xin Minhang¹

Affiliation:

1. Department of Medicinal Chemistry, School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi P.R. China

2. Department of Orthopedics, People’s Hospital of Fufeng County in Shaanxi Province, Baoji, Shaanxi P.R. China

3. Department of Pharmacy, Shaanxi University of Science & Technology, Xi’an, Shaanxi P.R. China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2019.1594777

Reference38 articles.

1. Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3Kδ

2. Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis

3. Discovery of Potent and Selective Tricyclic Inhibitors of Bruton’s Tyrosine Kinase with Improved Druglike Properties

4. The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bruton’s tyrosine kinase: A promising target for treating systemic lupus erythematosus;International Immunopharmacology;2024-12

2. The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease;Expert Opinion on Pharmacotherapy;2024-08-12

3. Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell‐Like Properties in Osteosarcoma;Environmental Toxicology;2024-06-26

4. A Comprehensive Review of Small-Molecule Inhibitors Targeting Bruton Tyrosine Kinase: Synthetic Approaches and Clinical Applications;Molecules;2023-12-11

5. Discovery of novel dual Bruton’s tyrosine kinase (BTK) and Janus kinase 3 (JAK3) inhibitors as a promising strategy for rheumatoid arthritis;Bioorganic & Medicinal Chemistry;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3